MORNING NEWS

The landmark decision sought by Bayer from the US Supreme Court on the issue of glyphosate is likely to be delayed.

UBS Group said it is launching a share buyback of up to $2 billion, delivering on its plans to hand money back to shareholders after the Swiss government proposed tougher capital rules for the bank earlier this month.

Nike (+10.7% after-hours) said it expects the decline in its sales and margins to slow in the current quarter as it continues to clear aged inventory and crank up marketing as its turnaround strategy progresses.

BP shares listed in New York advanced on Wednesday after the Wall Street Journal reported that the Dutch oil group Shell had begun talks to buy out its British rival.

FedEx is expecting mixed results in its current first quarter as tariffs weigh on its international shipping business.

Holcim’s spinoff of its North American operations offered a new way to invest in the construction business while largely avoiding the Trump administration’s tariff threats to the industry.

Oil prices had a volatile start to the week in Asia, rising before paring gains as markets watch to see how Iran will respond to U.S. attacks on three of its nuclear sites over the weekend.

The European Union approved UniCredit’s bid for Banco BPM with conditions, clearing a hurdle for the deal to go ahead after Italian officials tried to intervene on national security grounds.

Airbus said it would increase shareholder returns in the coming years, betting that robust demand for aircraft will continue to fuel growth.

Topic of the day Eli Lilly agreed to acquire Verve Therapeutics for about $1 billion upfront, adding a potential treatment for cardiovascular disease to its portfolio.